NASDAQ · Biotechnology

PMVP (PMVP) Stock

$1.11 -1.77% NASDAQ: PMVP Healthcare

Valuation

MetricValue
Price$1.11
Market Cap$59.20M
P/E Ratio-0.89
P/B Ratio0.67
P/S Ratio0.00
EPS (TTM)$-1.48
52-Week High$1.88
52-Week Low$0.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-74.29%
ROA-66.67%
ROCE-81.90%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio10.45

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-58.0M$-77.0M$-80.0M$-85.0M$-86.0M
Net Profit$-58.0M$-73.0M$-69.0M$-59.0M$-78.0M
EPS$-1.28$-1.61$-1.44$-1.14$-1.48
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$332.0M$270.0M$252.0M$191.0M$117.0M
Total Liabilities$23.0M$24.0M$26.0M$15.0M$12.0M
Cash$172.0M$108.0M$38.0M$41.0M$38.0M
Borrowings$11.0M$14.0M$13.0M$1.0M$1.0M

Latest News

PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks · Jun 10, 2026 Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity Insider Monkey · Jun 2, 2026 12 Health Care Stocks Moving In Wednesday's After-Market Session Benzinga · May 13, 2026 PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights GlobeNewswire · May 12, 2026 PMV Pharmaceuticals Announces Board Chair Transition GlobeNewswire · Apr 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-47.0M$-64.0M$-56.0M$-51.0M$-74.0M
Investing Cash Flow$-145.0M$-9.0M$-52.0M$53.0M$70.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-188.0M$-64.0M$-71.0M$2.0M$-3.0M
Free Cash Flow$-48.0M$-72.0M$-57.0M$-52.0M$-74.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-107.37%
Quick Ratio11.14
Interest Coverage—
Return 1Y6.02%
Return 3Y-78.21%
Return 5Y-95.81%

Ownership

Insiders Held3.35%
Institutions Held67.75%
Institutions Float Held70.10%
Institutional HolderSharesReport Date
BML Capital Management, LLC5,320,0002026-03-31
Tang Capital Management, LLC4,245,0852026-03-31
Sio Capital Management, LLC3,076,5802026-03-31
ArrowMark Colorado Holdings LLC2,872,7642026-03-31
Euclidean Capital Llc2,627,6432026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ATYR $0.49 +1.19% -0.72 $47.62M 0.00%
BMEA $1.22 +0.00% -1.20 $88.21M 0.00%
CBUS $1.93 +0.00% -0.50 $87.79M 0.00%
IMUXImmunic, Inc. $13.81 +3.14% -2.24 $188.11M 0.00%

About PMVP

PMVP is led by CEO David H. Mack, employs 47 people, headquartered in US, publicly traded since 2020.

PMVP stock trades at $1.11 with a market capitalization of $59.20M. The stock is valued at a price-to-earnings (P/E) ratio of -0.89, price-to-book of 0.67, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.96 and $1.88, and currently trades 41.0% below its 52-week high.

On profitability, PMVP generates a return on equity (ROE) of -74.29%, return on capital employed of -81.90%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides